SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-15-002302
Filing Date
2015-07-16
Accepted
2015-07-16 16:30:56
Documents
13

Document Format Files

Seq Description Document Type Size
1 F-3 zk1517058.htm F-3 743575
2 ARTICLES OF ASSOCIATION, AS AMENDED exhibit_2-1.htm EX-2.1 199317
3 FORM OF WARRANT exhibit_4-1.htm EX-4.1 101915
4 OPINION OF YIGAL ARNON & CO. exhibit_5-1.htm EX-5.1 33291
5 OPINION OF MORRISON & FOERSTER LLP exhibit_5-2.htm EX-5.2 24643
6 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES exhibit_12-1.htm EX-12.1 59432
7 CONSENT OF KESSELMAN AND KESSELMAN exhibit_23-1.htm EX-23.1 5526
8 STATEMENT OF ELIGIBILITY OF THE BANK OF NEW YORK MELLON, AS TRUSTEE exhibit_25-1.htm EX-25.1 99983
9 img001.jpg GRAPHIC 81681
10 biolinerx.jpg GRAPHIC 5680
11 pwc.jpg GRAPHIC 3415
12 yigalarnon.jpg GRAPHIC 10978
13 mofo.jpg GRAPHIC 5195
  Complete submission text file 0001178913-15-002302.txt   1416688
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-205700 | Film No.: 15991792
SIC: 2834 Pharmaceutical Preparations